(redirected from Cyclo-oxygenase)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Cyclo-oxygenase: Cyclooxygenase 2 inhibitors
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for cyclooxygenase

either of two related enzymes that control the production of prostaglandins and are blocked by aspirin

References in periodicals archive ?
Slides were then blocked again and treated with diluted primary antibody (rabbit anti-rat cyclo-oxygenase 2) in PBS.
placebo-treated individuals, suggest that cyclo-oxygenase inhibitors may
This has the potential to increase nociceptive transduction and NSAIDs may not be as effective in the presence of exogenously supplied prostaglandin, because the cyclo-oxygenase enzyme inhibited is not responsible for the prostaglandin concentration in this setting.
They all inhibit the activity of cyclo-oxygenase, or COX enzymes.
Evidence suggests that there may be a synergistic relationship between AVP receptors and cyclo-oxygenase enzyme during antipyresis, and the presence of AVP may enhance the efficacy of nonsteroidal antipyretic drugs.
THEY home in on an enzyme, cyclo-oxygenase (COX), that appears only at the site of an injury.
1992) had earlier found that specific inhibitors of the cyclo-oxygenase enzyme (i.
In addition, ionising radiation enhances lysosomal enzyme secretion and arachidonate release from membranes through lipo-oxygenase, cyclo-oxygenase and phospholipase activities, thus increasing the inflammatory cell response.
The advent of cyclo-oxygenase (COX-2) inhibitors was to reduce the well-documented GI adverse effects associated with the use of non-selective NSAIDs.
Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors.
Naproxcinod exerts its therapeutic effect through the well-described inhibition of the cyclo-oxygenase system and a sustained donation of nitric oxide.
Some were taking a high dose of lumiracoxib, a type of drug known as a cyclo-oxygenase inhibitor.
This naturally derived compound is not a selective cyclo-oxygenase 2 inhibitor.
To the Editor: The cyclo-oxygenase (2) (COX-2) inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) have been the subject of scrutiny generated mainly by evidence suggesting that rofecoxib is associated with increased cardiovascular risk.
Salix extracts have several anti-inflammatory targets including effects on both forms of cyclo-oxygenase.